Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study

Journal of Autoimmunity

Volumn 74, Issue , 2016, Pages 194-200

  Moroni, Gabriella ^a   Doria, Andrea ^b   Giglio, Elisa ^a   Imbasciati, Enrico ^c   Tani, Chiara ^d   Zen, Margherita ^b   Strigini, Francesca ^d   Zaina, Barbara ^a   Tincani, Angela ^e   Gatto, Mariele ^b   de Liso, Federica ^a   Grossi, Claudia ^f   Meroni, Pier Luigi ^f,g   Cabiddu, Gianfranca ^h   Messa, Piergiorgio ^a   Ravani, Pietro ⁱ   Mosca, Marta ^d  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e Rheumatology and Clinical Immunology Unit   (Italy)

^f ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h BROTZU HOSPITAL   (Italy)

ⁱ UNIVERSITY OF CALGARY   (Canada)

Author keywords

Lupus nephritis; Preeclampsia; Pregnancy; Renal flares; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY MASS; FEMALE; FIRST TRIMESTER PREGNANCY; HELLP SYNDROME; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MATERNAL CARE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; CLINICAL TRIAL; DISEASE EXACERBATION; IMMUNOLOGY; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROGNOSIS; RISK FACTOR;

ADULT; BIOMARKERS; DISEASE PROGRESSION; FEMALE; HELLP SYNDROME; HUMANS; LUPUS NEPHRITIS; PATIENT OUTCOME ASSESSMENT; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84978426202     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.06.012     Document Type: Article

References (52)

1. [1] Clowse, M.E., Jamison, M., Myers, E., James, A.H., A national study of the complications of lupus in pregnancy. Am. J. Obstet. Gynecol., 199, 2008 127.e1-6.
2. [2] Moroni, G., Quaglini, S., Banfi, G., Caloni, M., Finazzi, S., Ambroso, G., et al. Pregnancy in lupus nephritis. Am. J. Kidney Dis. 40 (2002), 713–720.
3. [3] Wagner, S.J., Craici, I., Reed, D., Norby, S., Bailey, K., Wiste, H.J., et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus 18 (2009), 342–347.
4. [4] Yang, H., Liu, H., Xu, D., Zhao, L., Wang, Q., Leng, X., et al. Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares a case control study. PLoS One, 9, 2014, e104375.
5. [5] Smyth, A., Oliveira, G.H., Lahr, B.D., Bailey, K.R., Norby, S.M., Garovic, V.D., A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin. J. Am. Soc. Nephrol. 5 (2010), 2060–2068.
6. [6] Kwok, L.W., Tam, L.S., Zhu, T., Leung, Y.Y., Li, E., Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus. Lupus 20 (2011), 829–836.
7. [7] Gladman, D.D., Tandon, A., Ibañez, D., Urowitz, M.B., The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J. Rheumatol. 37 (2010), 754–758.
8. [8] Saavedra, M.A., Cruz-Reyes, C., Vera-Lastra, O., Romero, G.T., Cruz-Cruz, P., Arias-Flores, R., et al. Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin. Rheumatol. 31 (2012), 813–819.
9. [9] Bramham, K., Hunt, B.J., Bewley, S., Germain, S., Calatayud, I., Khamashta, M.A., et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J. Rheumatol. 38 (2011), 1906–1913.
10. [10] Huong, D.L., Wechsler, B., Vauthier-Brouzes, D., Beaufils, H., Lefebvre, G., Piette, J.C., Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann. Rheum. Dis. 60 (2001), 599–604.
11. [11] Carmona, F., Font, J., Moga, I., Làzaro, I., Cervera, R., Pac, V., et al. Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am. J. Reprod. Immunol. 53 (2005), 182–188.
12. [12] Koh, J.H., Ko, H.S., Lee, J., Jung, S.M., Kwok, S.K., Ju, J.H., et al. Pregnancy and patients with preexisting lupus nephritis: 15 years of experience at a single center in Korea. Lupus 24 (2015), 764–772.
13. [13] Imbasciati, E., Tincani, A., Gregorini, G., Doria, A., Moroni, G., Cabiddu, G., et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol. Dial. Transpl. 24 (2009), 519–525.
14. [14] Hochberg, M.C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 40, 1997, 1725.
15. [15] Petri, M., Genovese, M., Engle, E., Hochberg, M., Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum. 34 (1991), 937–944.
16. [16] Moroni, G., Quaglini, S., Maccario, M., Banfi, G., Ponticelli, C., “Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int. 50 (1996), 2047–2053.
17. [17] Brown, M.A., Lindheimer, M.D., de Swiet, M., Van Assche, A., Moutquin, J.M., The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens. Pregnancy 20 (2001), IX–XIV.
18. [18] Audibert, F., Friedman, S.A., Frangieh, A.Y., Sibai, B.M., Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am. J. Obstet. Gynecol. 175 (1996), 460–464.
19. [19] de Liso, F., Matinato, C., Novembrino, C., Radice, A., Raffiotta, F., Ronchi, M., et al. Value of a commercial Kit for detecting anti-C1q antibodies and correlation with immunological and clincial activity of lupus nephritis. Clin. Chem. Lab. Med. 53 (2015), 1771–1777.
20. [20] Meroni, P.L., Macor, P., Durigutto, P., De Maso, L., Gerosa, M., Ferraresso, M., et al. Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery. Blood 127 (2016), 365–367.
21. [21] Weening, J.J., D'Agati, V.D., Schwartz, M.M., Seshan, S.V., Alpers, C.E., Appel, G.B., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J. Am. Soc. Nephrol. 15 (2004), 241–250.
22. [22] Julkunen, H., Jouhikainen, T., Kaaja, R., Leirisalo-Repo, M., Stephansson, E., Palosuo, T., et al. Fetal outcome in lupus pregnancy: a retrospective case-control study of 242 pregnancies in 112 patients. Lupus 2 (1993), 125–131.
23. [23] Oviasu, E., Hicks, J., Cameron, J.S., The outcome of pregnancy in women with lupus nephritis. Lupus 1 (1991), 19–25.
24. [24] Packham, D.K., Lam, S.S., Nicholls, K., Fairley, K.F., Kincaid-Smith, P.S., Lupus nephritis and pregnancy. Q. J. Med. 83 (1992), 315–324.
25. [25] Imbasciati, E., Surian, M., Bottino, S., Cosci, P., Colussi, G., Ambroso, G.C., et al. Lupus nephropathy and pregnancy. A study of 26 pregnanciesin patients with systemic lupus erythematosus and nephritis. Nephron 36 (1984), 46–51.
26. [26] Fischer-Betz, R., Specker, C., Brinks, R., Aringer, M., Schneider, M., Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatology 52 (2013), 1070–1076.
27. [27] Buyon, J.P., Kim, M.Y., Guerra, M.M., Laskin, C.A., Petri, M., Lockshin, M.D., et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study. Ann. Intern Med. 163 (2015), 153–163.
28. [28] Moroni, G., Quaglini, S., Maccario, M., Banfi, G., Ponticelli, C., Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int. 50:6 (1996), 2047–2053.
29. [29] Mosca, M., Bencivelli, W., Neri, R., Pasquariello, A., Batini, V., Puccini, R., et al. Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis. Kidney Int. 61:4 (2002), 1502–1509.
30. [30] Chawla, S., Marwaha, A., Agarwal, R., HELLP or help: a real challenge. J. Obstet. Gynaecol. India 65:3 (2015), 172–175.
31. [31] Hayslett, J.P., Lynn, R.I., Effect of pregnancy in patients with lupus nephropathy. Kidney Int. 18:2 (1980), 207–220.
32. [32] Clowse, M.E., Magder, L.S., Petri, M., The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J. Rheumatol. 38 (2011), 1012–1016.
33. [33] Borella, E., Lojacono, A., Gatto, M., Andreoli, L., Taglietti, M., Iaccarino, L., et al. Predictors of maternal and fetal complications in SLE patients: a prospective study. Immunol. Res. 60 (2014), 170–176.
34. [34] Zen, M., Ghirardello, A., Iaccarino, L., Tonon, M., Campana, C., Arienti, S., et al. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med. Wkly. 140 (2010), 187–201.
35. [35] Moroni, G., Radice, A., Giammarresi, G., Quaglini, S., Gallelli, B., Leoni, A., et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann. Rheum. Dis. 68 (2009), 234–237.
36. [36] Bock, M., Heijnen, I., Trendelenburg, M., Anti-C1q antibodies as a follow-up marker in SLE patients. PLoS One, 10(4), 2015, e0123572.
37. [37] Birmingham, D.J., Bitter, J.E., Ndukwe, E.G., Dials, S., Gullo, T.R., Conroy, S., et al. Relationship of circulating Anti-C3b and Anti-C1q IgG to lupus nephritis and its flare. Clin. J. Am. Soc. Nephrol. 11:1 (2016), 47–53.
38. [38] Kasturi, S., Sammaritano, L.R., Corticosteroids in lupus. Rheum. Dis. Clin. North Am. 42 (2016), 47–62.
39. [39] Versini, M., Jeandel, P.Y., Rosenthal, E., Shoenfeld, Y., Obesity in autoimmune diseases: not a passive bystander. Autoimmun. Rev. 13:9 (2014), 981–1000.
40. [40] Chakravarty, E.F., Colón, I., Langen, E.S., Nix, D.A., El-Sayed, Y.Y., Genovese, M.C., et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am. J. Obstet. Gynecol. 192 (2005), 1897–1904.
41. [41] Chakravarty, E.F., Nelson, L., Krishnan, E., Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 54 (2006), 899–907.
42. [42] Clowse, M.E., Lupus activity in pregnancy. Rheum. Dis. Clin. North Am. 33 (2007), 237–252.
43. [43] Cavallasca, J.A., Laborde, H.A., Ruda-Vega, H., Nasswetter, G.G., Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE). Clin. Rheumatol. 27 (2008), 41–46.
44. [44] Lateef, A., Petri, M., Managing lupus patients during pregnancy. Best. Pract. Res. Clin. Rheumatol. 27 (2013), 435–447.
45. [45] Sibai, B., Dekker, G., Kupferminc, M., Pre-eclampsia. Lancet 365 (2005), 785–799.
46. [46] de Jesus, G.R., Agmon-Levin, N., Andrade, C.A., Andreoli, L., Chighizola, C.B., Porter, T.F., et al. 14th international congress on antiphospholipid antibodies task force report on obstetric antiphospholipid syndrome. Autoimmun. Rev. 13 (2014), 795–813.
47. [47] do Prado, A.D., Piovesan, D.M., Staub, H.L., Horta, B.L., Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis. Obstet. Gynecol. 116 (2010), 1433–1443.
48. [48] Abou-Nassar, K., Carrier, M., Ramsay, T., Rodger, M.A., The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis. Thromb. Res. 128 (2011), 77–85.
49. [49] Moroni, G., Ponticelli, C., The risk of pregnancy in patients with lupus nephritis. J. Nephrol. 16 (2003), 161–167.
50. [50] Qazi, U.M., Petri, M., Autoantibodies, low complement, and obesity predict preeclampsia in SLE: a case-control study. Arthritis Rheum., 54(9 suppl), 2006, S264.
51. [51] Al Sawah, S., Zhang, X., Zhu, B., Magder, L.S., Foster, S.A., Iikuni, N., et al. Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus- the Hopkins Lupus Cohort. Lupus Sci. Med., 2, 2015, e000066.
52. [52] Spradley, F.T., Palei, A.C., Granger, J.P., Immune mechanisms linking obesity and preeclampsia. Biomolecules 5 (2015), 3142–3176.